Facial-onset sensory and motor neuronopathy with myasthenia gravis: A case report

Medicine (Baltimore). 2023 Nov 17;102(46):e34215. doi: 10.1097/MD.0000000000034215.

Abstract

Rationale: Facial-onset sensory and motor neuronopathy (FOSMN) is a greatly rare disease, so far, autopsy evidence that is associated with neurodegenerative. Myasthenia gravis (MG) is an antibody-mediated and complement-involved acquired autoimmune disorder of the post-synaptic neuromuscular junction. There have been few reports about if there is related between the 2. In this study, we present the case of a man who was diagnosed as FOSMN with MG in continuity.

Patient concerns: The patient chief complaints were right-side facial numbness and right-eyelid incomplete closure, followed by slurred speech and dysphagia, and the symptoms gradually progressed. The patient serum was positive for anti-AchR and anti-Titin antibodies.

Diagnoses: The patient was diagnosed FOSMN with MG.

Interventions: The patient symptoms were relieved after pyridostigmine bromide and prednisolone treatment.

Outcomes: Symptoms have improved.

Lessons: Facial-onset sensory and motor neuronopathy and MG have disparate clinical features. Therefore, we reported a rare case in which the 2 conditions concurrently existed. Immune dysfunction might be the pathogenesis of this association, while there is no definite evidence to support it, further studies are needed.

Publication types

  • Case Reports

MeSH terms

  • Deglutition Disorders*
  • Humans
  • Male
  • Myasthenia Gravis* / complications
  • Myasthenia Gravis* / diagnosis
  • Myasthenia Gravis* / drug therapy
  • Pyridostigmine Bromide

Substances

  • Pyridostigmine Bromide